Compare MLSS & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MLSS | ALUR |
|---|---|---|
| Founded | 1989 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.9M | 18.9M |
| IPO Year | 1995 | N/A |
| Metric | MLSS | ALUR |
|---|---|---|
| Price | $0.25 | $1.20 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | $1.00 | ★ $9.25 |
| AVG Volume (30 Days) | ★ 297.3K | 108.2K |
| Earning Date | 11-13-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $8,929,517.00 | ★ $17,208,000.00 |
| Revenue This Year | $8.95 | N/A |
| Revenue Next Year | $7.51 | $15.47 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 0.59 | N/A |
| 52 Week Low | $0.22 | $1.02 |
| 52 Week High | $1.32 | $7.12 |
| Indicator | MLSS | ALUR |
|---|---|---|
| Relative Strength Index (RSI) | 35.46 | 38.15 |
| Support Level | $0.26 | $1.17 |
| Resistance Level | $0.30 | $1.57 |
| Average True Range (ATR) | 0.03 | 0.18 |
| MACD | -0.00 | -0.04 |
| Stochastic Oscillator | 35.80 | 25.00 |
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.